Healthcare provider profile · identity verified

Nathan L Beebe, MD

Family Practice · FRANKLIN, OH · NPI 1053331009

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	732	210
Lisinopril	Lisinopril	524	145
Rosuvastatin Calcium	Rosuvastatin Calcium	369	109
Amlodipine Besylate	Amlodipine Besylate	341	101
Levothyroxine Sodium	Levothyroxine Sodium	335	92
Omeprazole	Omeprazole	284	89
Metoprolol Succinate	Metoprolol Succinate	275	80
Pioglitazone Hcl	Pioglitazone Hcl	217	63
Furosemide	Furosemide	205	68
Nifedipine Er	Nifedipine	176	45
Albuterol Sulfate Hfa	Albuterol Sulfate	164	55
Pantoprazole Sodium	Pantoprazole Sodium	157	47
Losartan Potassium	Losartan Potassium	149	46
Carvedilol	Carvedilol	140	42
Tamsulosin Hcl	Tamsulosin Hcl	136	42
Metformin Hcl	Metformin Hcl	132	45
Olmesartan Medoxomil	Olmesartan Medoxomil	131	41
Eliquis	Apixaban	130	40
Clonazepam	Clonazepam	123	22
Tramadol Hcl	Tramadol Hcl	118	32
Methylprednisolone	Methylprednisolone	115	98
Metoprolol Tartrate	Metoprolol Tartrate	114	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	113	36
Pravastatin Sodium	Pravastatin Sodium	112	28
Allopurinol	Allopurinol	109	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	108	29
Simvastatin	Simvastatin	100	27
Atenolol	Atenolol	96	26
Clopidogrel	Clopidogrel Bisulfate	95	30
Meloxicam	Meloxicam	93	32
Potassium Chloride	Potassium Chloride	93	26
Citalopram Hbr	Citalopram Hydrobromide	88	30
Sertraline Hcl	Sertraline Hcl	87	21
Zolpidem Tartrate	Zolpidem Tartrate	84	20
Lorazepam	Lorazepam	83	16
Metformin Hcl Er	Metformin Hcl	80	25
Gabapentin	Gabapentin	78	29
Januvia	Sitagliptin Phosphate	77	18
Cephalexin	Cephalexin	72	56
Esomeprazole Magnesium	Esomeprazole Magnesium	71	21
Duloxetine Hcl	Duloxetine Hcl	69	21
Montelukast Sodium	Montelukast Sodium	69	22
Propranolol Hcl	Propranolol Hcl	68	16
Ozempic	Semaglutide	64	15
Escitalopram Oxalate	Escitalopram Oxalate	60	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	59	16
Hydrochlorothiazide	Hydrochlorothiazide	59	15
Celecoxib	Celecoxib	58	20
Trazodone Hcl	Trazodone Hcl	57	17
Valsartan	Valsartan	56	18
Fluoxetine Hcl	Fluoxetine Hcl	52	15
Azithromycin	Azithromycin	51	45
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	13
Farxiga	Dapagliflozin Propanediol	50	16
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	50	16
Synthroid	Levothyroxine Sodium	50	15
Xarelto	Rivaroxaban	49	12
Venlafaxine Hcl Er	Venlafaxine Hcl	48	suppressed
Methocarbamol	Methocarbamol	47	32
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	14
Fenofibrate	Fenofibrate Nanocrystallized	43	12
Buspirone Hcl	Buspirone Hcl	40	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	40	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	12
Clonidine Hcl	Clonidine Hcl	37	11
Fluticasone Propionate	Fluticasone Propionate	37	14
Glipizide	Glipizide	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Torsemide	Torsemide	35	12
Spironolactone	Spironolactone	34	14
Ibuprofen	Ibuprofen	33	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Rybelsus	Semaglutide	33	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	27
Alendronate Sodium	Alendronate Sodium	32	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	16
Donepezil Hcl	Donepezil Hcl	28	suppressed
Naproxen	Naproxen	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	26	18
Levofloxacin	Levofloxacin	26	18
Ondansetron Odt	Ondansetron	26	13
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Prednisone	Prednisone	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	suppressed
Finasteride	Finasteride	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Fluconazole	Fluconazole	19	16
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Nystatin	Nystatin	17	suppressed
Risperidone	Risperidone	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	15
Colchicine	Colchicine	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	12
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Famotidine	Famotidine	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Levetiracetam Er	Levetiracetam	12	suppressed
Topiramate	Topiramate	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Edarbi	Azilsartan Medoxomil	11	suppressed
Linzess	Linaclotide	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Vraylar	Cariprazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error